HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home.
HeartBeam has announced a collaboration with the Icahn School of Medicine at Mount Sinai in New York to accelerates development of personalised cardiac AI on this platform for wellness and clinical applications, including assessing heart attack risk.
The partnership marks a significant milestone in the Company's long-term strategy to build an ecosystem around its platform and strengthen its leadership in AI-enabled cardiac monitoring.
According to Towards Healthcare, the U.S. wireless cardiac monitoring systems market is projected to experience significant growth, with estimates suggesting the market size will increase from USD 4.34 billion in 2026 to approximately USD 12.84 billion by 2035, representing a compound annual growth rate (CAGR) of 12.8% from 2026 to 2035. Growth is driven by the rising prevalence of cardiac rhythm disorders and the need of monitoring solution that allows the adoption AI enable wearable and patch-based technologies, which enhance diagnostic accuracy and efficiency.
About HeartBeams
HeartBeam, Inc is a medical technology company dedicated to transforming the detection and monitoring of critical cardiac conditions. This platform technology is designed for portable devices that can be used wherever the patient is to deliver actionable heart intelligence.
Chief Executive Officer of HeartBeam, Robert Eno, said We believe expanding access to 12-lead ECG data assessment beyond the clinic is one of the biggest opportunities. A core value driver of the collaboration is HeartBeam’s ability to generate longitudinal, high-fidelity, synthesised 12-lead ECG datasets from patients in the home setting. Data engine that is expected to support the development of increasingly personalised algorithms positioning HeartBeam to expand into new clinical indications and reimbursement pathways.
About the Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metro area. It advances health for all people, everywhere, by taking on the most complex health care challenges of our time. It applies new scientific learning, developing safer, more effective treatments; educating the next generation of medical leaders and innovators; and supporting local communities by delivering high-quality care to all who need it.
A recent report by Towards Healthcare highlights that the U.S. wireless cardiac monitoring systems market is witnessing growth due to a focus on patient outcomes and quality metrics, leading to a greater demand for wireless cardiac monitoring systems, with wireless connectivity, and miniaturisation enhancing the capabilities of cardiac monitoring devices.